MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit

By Dean Seal


MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesn't meet regulatory requirements for a certain classification sought by the...

Related Keywords

Georgia , United States , Joseph Capper , Public Health Service , Mimedx Group , Drug Administration , Dean Seal , Medx Group , Executive Joseph Capper , Dow Jones , Markets ,